Voglibose 0.3mg Tablet in PCD pharma franchise in Hyderabad

Voglibose 0.3mg Tablet in pharmaceutical manufacturing company in Mumbai

Voglibose 0.3mg Tablet in pharma franchise in Pune

Voglibose 0.3mg Tablet in pharma suppliers in Delhi

Voglibose 0.3mg Tablet in pharma export companies in Kolkata
Voglibose 0.3mg Tablet in pharma franchise opportunities in Bengaluru

Home/Products /voglibose-i-point-p-point-0-point-3-tablets

Vogliviga 0.3 Tablet

Composition : Voglibose I.P. 0.3 Tablets

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹99/-

Vogliviga 0.3 Tablet contains Voglibose 0.3mg, an alpha-glucosidase inhibitor used to control postprandial (after meal) blood sugar levels in patients with type 2 diabetes mellitus. It works by delaying the breakdown and absorption of complex carbohydrates in the small intestine, thereby reducing the rise in blood glucose after meals. This makes it an effective add-on therapy to diet, exercise, and other oral antidiabetic agents, especially for managing postprandial hyperglycemia.

Read More

About the Product

Vogliviga 0.3 Tablet contains Voglibose 0.3mg, an alpha-glucosidase inhibitor used to control postprandial (after meal) blood sugar levels in patients with type 2 diabetes mellitus. It works by delaying the breakdown and absorption of complex carbohydrates in the small intestine, thereby reducing the rise in blood glucose after meals. This makes it an effective add-on therapy to diet, exercise, and other oral antidiabetic agents, especially for managing postprandial hyperglycemia.

Common side effects include flatulence, abdominal discomfort, bloating, and mild diarrhea. These effects usually subside as the body adjusts to the medication. Serious gastrointestinal effects are rare.

Indicated for type 2 diabetes mellitus patients, particularly for controlling post-meal blood sugar spikes in combination with other antidiabetic medications.

Not suitable for individuals with gastrointestinal disorders like inflammatory bowel disease, intestinal ulcers, or chronic digestive problems. Blood sugar levels should be monitored regularly. Use with caution in patients with liver or kidney impairment.

Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation